Tacrolimus alleviates LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling in mice
Authors:
Open Access
- 9 December 2021
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 26 (2) , 507-514
Abstract
Lipopolysaccharide (LPS)‐induced sepsis‐associated acute kidney injury (SA‐AKI) is a model of clinical serious care syndrome, with high morbidity and mortality. Tacrolimus (TAC), a novel immunosuppressant that inhibits inflammatory response, plays a pivotal role in kidney diseases. In this study, LPS treated mice and cultured podocytes were used as the models of SA‐AKI in vivo and in vitro, respectively. Medium‐ and high‐dose TAC administration significantly attenuated renal function and renal pathological manifestations at 12, 24 and 48 h after LPS treatment in mice. Moreover, the Toll‐like receptor 4 (TLR4)/myeloid differential protein‐88 (MyD88)/nuclear factor‐kappa (NF‐κB) signalling pathway was also dramatically inhibited by medium‐ and high‐dose TAC administration at 12, 24 and 48 h of LPS treatment mice. In addition, TAC reversed LPS‐induced podocyte cytoskeletal injury and podocyte migratory capability. Our findings indicate that TAC has protective effects against LPS‐induced AKI by inhibiting TLR4/MyD88/NF‐κB signalling pathway and podocyte dysfunction, providing another potential therapeutic effects for the LPS‐induced SA‐AKI.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20181150)
This publication has 27 references indexed in Scilit:
- Tacrolimus in preventing transplant rejection in Chinese patients – optimizing useDrug Design, Development and Therapy, 2015
- TLR2, TLR4 and the MYD88 Signaling Pathway Are Crucial for Neutrophil Migration in Acute Kidney Injury Induced by SepsisPLOS ONE, 2012
- Tacrolimus Improves the Proteinuria Remission in Patients with Refractory IgA NephropathyAmerican Journal of Nephrology, 2012
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic NephropathyJournal of the American Society of Nephrology, 2012
- Toll-Like Receptor 4 Inhibitor TAK-242 Attenuates Acute Kidney Injury in Endotoxemic SheepAnesthesiology, 2011
- Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injuryKidney International, 2011
- Septic Acute Kidney Injury in Critically Ill PatientsClinical Journal of the American Society of Nephrology, 2007
- Lipopolysaccharide signaling in endothelial cellsLaboratory Investigation, 2006
- Acute Renal Failure in Critically Ill PatientsA Multinational, Multicenter StudyJAMA, 2005
- Acute Renal Failure and SepsisNew England Journal of Medicine, 2004